about
Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.Examining the multifactorial nature of cognitive aging with covariance analysis of positron emission tomography dataApplications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases.The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.Sensitivity and specificity of diagnostic accuracy in Alzheimer's disease: a synthesis of existing evidence.Donepezil in Alzheimer's disease: From conventional trials to pharmacogeneticsUse of laboratory and imaging investigations in dementiaCharacterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.Strategies for molecular imaging dementia and neurodegenerative diseases.Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.
P2860
Q30996727-D004364D-FEFE-4DA6-B9E7-6CA3E6BBE8BFQ33497053-C5B6FBBA-B7BD-427A-827D-9485227997CAQ33888328-6A2387ED-8E07-4D19-93BB-01375AADD82FQ34296479-5A6AF99B-8B97-45AC-8F91-3BAEAA1CCECFQ34728483-7A472A05-9DA9-40B3-9D02-1A393B5892A6Q34965949-8C740549-BB9B-4888-86E7-048B8D6E8D6AQ35576641-A9A54EB1-1DE3-4AB8-8482-38C65FF77822Q36819076-052A0C13-DBBA-4205-B854-8502B5A3F2FEQ36853915-687D3406-355B-4F1A-A20D-81679BB45A2FQ37358672-43E25A57-5788-4E12-906B-1EC4A390C554Q40883032-0D926713-5DF0-4F0D-9256-151EC512E24AQ42126269-22C526D6-6043-40AA-AA50-E0704E2CDB74Q47134489-10BDF2EB-FE10-4481-874F-52ACD41DEF3A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Molecular neuroimaging in Alzheimer's disease.
@ast
Molecular neuroimaging in Alzheimer's disease.
@en
type
label
Molecular neuroimaging in Alzheimer's disease.
@ast
Molecular neuroimaging in Alzheimer's disease.
@en
prefLabel
Molecular neuroimaging in Alzheimer's disease.
@ast
Molecular neuroimaging in Alzheimer's disease.
@en
P2860
P356
P1433
P1476
Molecular neuroimaging in Alzheimer's disease.
@en
P2860
P304
P356
10.1602/NEURORX.1.2.206
P577
2004-04-01T00:00:00Z